Companies: 10,795·Total market cap: $144.5T
Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQOTCHealthcare
$0.00
$-0.00(-99.00%)
Market Cap$122
P/E Ratio
52W High
52W Low
Overview

Allena Pharmaceuticals, Inc. (ALNAQ) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ALNAQ · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.54alnaq eps ttm · alnaq earnings per shareEarnings history
PE Ratio (TTM)alnaq pe ratio ttm · alnaq price to earningsPE Ratio deep dive
Revenue (TTM)0.00alnaq revenue ttm · alnaq annual revenueFull revenue history
Dividend YieldNo Dividenddoes alnaq pay dividends · alnaq dividend yieldDividend history
Shares Outstanding68.0Malnaq shares outstanding · alnaq floatShares outstanding history
Next EarningsTBAalnaq earnings date · alnaq next earningsEarnings history

Financial Snapshot

Full Financials
FY 2021Revenue$0.00
201920202021
allena pharmaceuticals, inc. revenue · alnaq revenue 2021
FY 2021Net Income-$49.6M▼ 51.90% YoY
201920202021
allena pharmaceuticals, inc. net income · alnaq profit 2021
FY 2021EPS$-0.73▲ +27.72% YoY
201920202021
alnaq eps · allena pharmaceuticals, inc. earnings per share 2021
TTM:Revenue: $0.00Net Income: -$45.1MEPS: $-0.54View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold4 analystsis alnaq a buy · alnaq analyst rating
Strong Buy
0
Buy
0
Hold
4
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.00Current
$Avg Target
$High
alnaq price target · alnaq 12 month forecast

Total: 4 · Buy rate: 0.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M-99.00%
3M-99.00%
YTD+0.00%
1Y-99.99%
5Y-100.00%

About Allena Pharmaceuticals, Inc.

CEO
IPO DateNov 2, 2017
Employees12
CountryUS

Allena Pharmaceuticals, Inc. Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the Unite…

what is allena pharmaceuticals, inc. · alnaq stock overview · allena pharmaceuticals, inc. company profile · who is allena pharmaceuticals, inc. ceo · alnaq OTC · allena pharmaceuticals, inc. headquarters · allena pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Allena Pharmaceuticals, Inc. (ALNAQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 2, 2017. As of the latest trading session, ALNAQ stock price is $0.00, with a market capitalization of $122. The stock has returned -99.99% over the past 12 months and +0.00% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Allena Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2021, Allena Pharmaceuticals, Inc. reported revenue of — and net income of -$49.6M. For detailed data — including Allena Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Allena Pharmaceuticals, Inc. (ALNAQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol ALNAQ. The 52-week range is $1.00 – $6.00.

ALNAQ stock priceALNAQ quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice